News and Announcements
Actinogen Medical Successfully Treats First Australian & US Patients & Reports Cash of $3.9m
- Published August 11, 2017 12:00AM UTC
- Publisher Wholesale Investor
- Categories Company Updates
Actinogen Medical (ASX:ACW) has recently provided a summary of its progress over the quarter ended June 30, 2017.
KEY TAKEAWAYS:
- The company achieved significant milestones with Actinogen’s Alzheimer’s disease trial, with the successful treatment of the first Australian and US patients.
- Represents a landmark in the global search for a new effective treatment.
- Additional trial sites in Australia, the US and the UK are expected soon commence enrolling patients, with the final patient planned to be enrolled by Q4 2018.
- Cash at 30th June 2017 of $3.989million.
The Company remains focused on ensuring the trial progresses as planned and looks forward to updating the market on its progress over the near medium term.
“We are delighted to have had such a strong momentum behind XanADu, a ground-breaking trial that shows Australia is leading the way in developing this promising new treatment for Alzheimer’s disease,” said Dr Bill Ketelbey, CEO of Actinogen Medical.
Company Updates
Dogs First to Reduce Risk: QBiotics’ Smarter Path to Oncology Markets
QBiotics took a compound derived from a north Queensland rainforest tree all the way to veterinary registration before pursuing human oncology to de-risk its human cancer programme. Interim CEO Ebru Davidson argues that sequence – now backed by early responses across several human cancers – is the company’s real asset. The story that pulled Wholesale […]
Built on discipline, not complexity: inside an ASX equities income strategy
Haydn Froggatt and Zac Brabin have decades of derivatives experience between them and access to almost any strategy in the market. They use two of the simplest structures available, and wrote 202 positions with them last year. Published by Fairway Capital Management. Based on an interview with co-founders Haydn Froggatt and Zac Brabin. Two traders, […]
BlackRock has named the next Economy. What this latest paper means for Private Market Investors.
BlackRock has put a name on something the smart money has been circling for two years. Its digital assets research team calls it the machine-native economy. The thesis fits in one line. AI is machine-native intelligence. Digital assets are machine-native money. Both are built on the same architecture, and they are converging into a single […]
Backed By Leading Investment Groups and Family Offices
